News

Cartherics CEO Dr Ian Nisbet presents at the Emergence Investment Conference

Cartherics CEO Dr Ian Nisbet presents at the Emergence Investment Conference

Cartherics is pleased to share Dr Ian Nisbet’s presentation at the Emergence Investment Conference in Sydney, where he outlined the Company’s strategy, progress and vision for transforming women’s health through pioneering cellular immunotherapies.

Speaking to an audience of investors and industry leaders, Dr Nisbet highlighted Cartherics’ unique focus on developing off-the-shelf cell therapies designed specifically to […]

Christine Filippis2026-03-02T15:41:19+11:00March 2nd, 2026|

Prof. Alan Trounson to present lecture at KAUST on immune cell therapies for women’s health

Prof. Alan Trounson to present lecture at KAUST on immune cell therapies for women’s health

Cartherics is pleased to announce that Professor Alan Trounson AO, Deputy Chair, will deliver an invited lecture at King Abdullah University of Science and Technology (KAUST) titled: A Platform Technology for Immune Targeting Cancer and Endometriosis – A Women’s Health Focus. The lecture will take place on February 4, at 10.30am (AST).

In this lecture, Professor […]

Christine Filippis2026-02-03T10:51:29+11:00February 3rd, 2026|

Cartherics to present at the ANZ Biologics Festival 2026

Cartherics to present at the ANZ Biologics Festival 2026

Cartherics is pleased to announce that Dr Madeline Cao, Head of Manufacturing Development and Dr Walid Azar, Chief Scientific Officer, will present at the upcoming ANZ Biologics Festival in Melbourne, showcasing Cartherics’ progress in building a discovery-to-clinic engine for scalable, off-the-shelf cell therapies.

Dr. Cao will deliver a presentation titled, ‘Off-the-Shelf’ Immuno-Cell Therapies: Manufacturing […]

Christine Filippis2026-02-02T11:50:48+11:00February 2nd, 2026|

Cartherics granted key patent in China for TAG-72 CAR gene-modified stem cells

Cartherics granted key patent in China for TAG-72 CAR gene-modified stem cells

Melbourne, Australia, 29 January 2026 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian cancer and endometriosis, is pleased to announce the granting of a second patent in China for “Genetically modified cells and uses thereof” by the Chinese Patent Office.

This patent extends the Company’s […]

Christine Filippis2026-01-29T11:38:48+11:00January 29th, 2026|

Message from the CEO

Message from the CEO

With the end of the year fast approaching, it is timely to take a step back and reflect on the challenges and achievements for 2025.

We began the year with optimism and momentum, having completed a major financing round late in 2024 (thanks to our incredible group of investors). We were preparing for filing an IND […]

Christine Filippis2025-12-16T15:36:54+11:00December 16th, 2025|

Cartherics to participate in prominent biotech investor conferences during JPM Healthcare Week

Cartherics to participate in prominent biotech investor conferences during JPM Healthcare Week

Dr Ian Nisbet, Chief Executive Officer, is attending both the RESI Investor Conference and BIO Partnering
Dr Vera Evtimov, Director of Operations, is presenting at Biotech Showcase

Melbourne, Australia, 16 December 2025 –  Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead […]

Christine Filippis2025-12-16T14:31:22+11:00December 16th, 2025|

Cartherics Team Offsite: Stronger Together

Cartherics Team Offsite: Stronger Together

The Cartherics team recently gathered at the RACV Club in Healesville for a dynamic and inspiring offsite event focused on collaboration, growth, and celebrating our shared mission.

The theme of the offsite, Stronger Together, set a positive and inclusive tone that resonated throughout the event, encouraging everyone to embrace teamwork, challenges and shared success as we […]

Christine Filippis2025-12-10T10:43:26+11:00December 10th, 2025|

Cartherics to present at the ISSCR 2025 Boston International Symposium

Cartherics to present at the ISSCR 2025 Boston International Symposium

Cartherics’ Deputy Chair, Prof. Alan Trounson AO will be presenting at ISSCR 2025 on Friday 12^th December, 2025 at 3.25pm (US EST)

Melbourne, Australia, 8 December 2025 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian cancer and […]

Christine Filippis2025-12-08T16:29:33+11:00December 8th, 2025|

Launch of Evinco Therapeutics: A pioneering biotech company advancing immune therapies for Alzheimer’s disease

Launch of Evinco Therapeutics: A pioneering biotech company advancing immune therapies for Alzheimer’s disease

Evinco Therapeutics is an Australian start-up on a mission to transform the treatment of Alzheimer’s disease and other neuroinflammatory conditions

Melbourne, Australia, 4 December 2025 – An exciting chapter in medical innovation begins today with the official launch of Evinco Therapeutics Pty Ltd (“Evinco” or “Company”), a Melbourne-based biotechnology company developing advanced immune-based therapies for […]

Christine Filippis2025-12-04T15:17:50+11:00December 4th, 2025|

Cartherics appoints Dr Ian Nisbet as Chief Executive Officer

Cartherics appoints Dr Ian Nisbet as Chief Executive Officer

Dr Ian Nisbet appointed as Chief Executive Officer
Prof Alan Trounson AO will move into the role of Deputy Chair of the Board

Melbourne, Australia, 28 November 2025 –  Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian […]

Christine Filippis2025-11-28T10:15:10+11:00November 28th, 2025|

About us

Sign up to our newsletter